Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabolic enzymes and transporters

MLA

Takahiro Fukuhara, et al. “Evaluation of Drug-Drug Interaction of Lusutrombopag, a Thrombopoietin Receptor Agonist, via Metabolic Enzymes and Transporters.” European Journal of Clinical Pharmacology, vol. 76, no. 12, July 2020, pp. 1659–65. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e2fda71dd1ed11251dec1c29d8d8293d&authtype=sso&custid=ns315887.

APA

Takahiro Fukuhara, Takeshi Kano, Yuji Inoue, Toshihiro Wajima, & Takayuki Katsube. (2020). Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabolic enzymes and transporters. European Journal of Clinical Pharmacology, 76(12), 1659–1665.

Chicago

Takahiro Fukuhara, Takeshi Kano, Yuji Inoue, Toshihiro Wajima, and Takayuki Katsube. 2020. “Evaluation of Drug-Drug Interaction of Lusutrombopag, a Thrombopoietin Receptor Agonist, via Metabolic Enzymes and Transporters.” European Journal of Clinical Pharmacology 76 (12): 1659–65. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e2fda71dd1ed11251dec1c29d8d8293d&authtype=sso&custid=ns315887.